Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 92.4B | 105.6B | 112.8B | 117.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 18.7B | 12.4B | 19.8B | 14.2B |
| Other operating expenses | 18.8B | 38.9B | 38.7B | 33.1B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 13.0B | 14.2B | 9.4B | 48.4B |
| Tax provision | 0 | 18.9B | 0 | 0 |
| Net income | 13.0B | -4.7B | 9.4B | 48.4B |
| Basic EPS | 0.3 | — | — | — |
| Diluted EPS | 0.3 | — | — | — |
| Basic average shares | 38.8B | — | — | — |
| Diluted average shares | 38.8B | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |